Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2021-01-07 | 2021-01-06 |
| Drug Identification Number | 02266342 | 02266342 |
| Brand name | FLUMAZENIL INJECTION | FLUMAZENIL INJECTION |
| Common or Proper name | Flumazenil Injection | Flumazenil Injection |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | FLUMAZENIL | FLUMAZENIL |
| Strength(s) | 0.1MG | 0.1MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 0.1 mg/mL MD Vial 5 mL | 0.1 mg/mL MD Vial 5 mL |
| ATC code | V03AB | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2021-01-06 | 2021-01-06 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be placing our Flumazenil Injection 0.1 mg/mL MD Vial 5 mL on allocation. Contract customers will be allocated 50% of their historical average monthly volumes, effective today, January 6, 2021. | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be placing our Flumazenil Injection 0.1 mg/mL MD Vial 5 mL on allocation. Contract customers will be allocated 50% of their historical average monthly volumes, effective today, January 6, 2021. |
| Health Canada comments |